This technology is comprised of a mouse monoclonal antibody that specifically recognizes human EAF1, a protein of approximately 45 kDa. It has been meticulously validated for multiple applications, including Western Blot—using a 1:10,000 dilution for transfected proteins and a 1:1,000 dilution for endogenous proteins—and for immunoprecipitation protocols. Developed in parallel with a similar, yet distinct, antibody from another hybridoma, this tool showcases high specificity to human EAF1 with no confirmed cross-reactivity with proteins from other species. Comprehensive in vitro data and NIH-supported research further underpin its credibility.